Luoyang Osteopathy hospital of Henan Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2017
NCT03309501
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Luoyang Osteopathy hospital of Henan

Active Ingredients

Drugs in Phase 3 Trials (2)

qi-zheng-xiao-tong (1 trial)

tong-luo-qu-tong (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Musculoskeletal Diseases (Phase 3)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2